When Plans Change: Surgical Implantation of a Transcatheter Pulmonary Valve in Hypoplastic Left Heart Syndrome - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

When Plans Change: Surgical Implantation of a Transcatheter Pulmonary Valve in Hypoplastic Left Heart Syndrome

  • By

  • November 16, 2026

  • 6 min

Share

Clinical Scorecard: When Plans Change: Surgical Implantation of a Transcatheter Pulmonary Valve in Hypoplastic Left Heart Syndrome

At a Glance

CategoryDetail
ConditionHypoplastic left heart syndrome (HLHS) with pulmonary valve injury and regurgitation before Stage I palliation
Key MechanismsA pulmonary cusp avulsion caused severe valve dysfunction; a surgically implanted Melody transcatheter valve replaced the irreparable valve and served as a short-term bridge to decision-making.
Target PopulationNeonates with HLHS and pulmonary valve dysfunction before Stage I palliation, particularly when repair is not feasible.
Care SettingSpecialized pediatric cardiac care involving cardiac surgery, interventional cardiology, imaging, cardiac intensive care, ECMO, and catheterization teams.

Key Highlights

  • A term neonate with HLHS developed pulmonary regurgitation and a pulmonary cusp avulsion after pulmonary blood flow restrictor placement.
  • At 10 days of age, the patient underwent surgical implantation of a shortened 22-mm Melody valve across the pulmonary annulus.
  • Postoperative echocardiography showed no stenosis, regurgitation, paravalvular leak, or right ventricular outflow tract obstruction; the patient was decannulated from VA-ECMO.
  • The valve was used as a short-term bridge to decision-making, not as definitive palliation; the patient later underwent PDA stent placement.
  • The authors report that a review of 3,807 patients with single-ventricle physiology identified 12 semilunar valve replacements, none before Stage I palliation.

Guideline-Based Recommendations

Diagnosis

  • In the reported case, echocardiography identified new pulmonary regurgitation and a 3-mm pulmonary valve leaflet defect after flow restrictor implantation.
  • Intraoperative assessment found an irreparable left pulmonary cusp free-margin avulsion with tissue too friable for suture repair.

Management

  • The team used a surgically implanted Melody valve as a short-term bridge while assessing the patient’s overall condition and future treatment pathway.
  • The valve was shortened, hand-crimped over a 14-mm balloon, positioned across the pulmonary annulus, and secured with three interrupted sutures.
  • The patient subsequently underwent PDA stent placement as palliation; the article states that transplant listing was the only viable long-term option if extracardiac conditions were not prohibitive.

Monitoring & Follow-up

  • Postoperative echocardiography assessed ventricular function, valve stenosis or regurgitation, paravalvular leak, and outflow tract obstruction.
  • Cardiac catheterization later confirmed a well-seated valve without stenosis or regurgitation.

Risks

  • Potential risks include outflow tract obstruction from proximal valve placement and coronary compression or aortic root compromise from overdilation.
  • The article notes limitations of using a transcatheter valve for open surgical placement in this anatomy and reduced tolerance for hemodynamic compromise with single-ventricle physiology.

Patient & Prescribing Data

The report describes one term neonate with HLHS, mitral stenosis, aortic atresia, pulmonary overcirculation, and an irreparable pulmonary cusp avulsion before Stage I palliation.

A Melody transcatheter valve was surgically implanted at 10 days of age as a short-term bridge. The report does not establish this approach as definitive palliation or provide comparative treatment data.

Clinical Best Practices

  • Use multidisciplinary discussion when unexpected intraoperative findings make the original surgical plan infeasible.
  • When considering this approach, account for valve position, preservation of pulmonary artery tissue for closure, right ventricular outflow tract obstruction, coronary compression, and aortic root compromise.
  • Treat the reported valve implantation as a short-term strategy; the article emphasizes that it was not definitive repair or a shortcut to Stage I palliation.
  • The authors advise early referral for suspected or confirmed HLHS, prenatally when possible or as soon as possible after diagnosis.

Related Resources & Content

Original Source(s)

Related Content